Cargando…
Vaccines for immunoprevention of DNA mismatch repair deficient cancers
The development of cancer vaccines to induce tumor-antigen specific immune responses was sparked by the identification of antigens specific to or overexpressed in cancer cells. However, weak immunogenicity and the mutational heterogeneity in many cancers have dampened cancer vaccine successes. With...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226910/ https://www.ncbi.nlm.nih.gov/pubmed/35732349 http://dx.doi.org/10.1136/jitc-2021-004416 |